| Literature DB >> 24756923 |
Rakesh K Pathak1, Christopher D McNitt, Vladimir V Popik, Shanta Dhar.
Abstract
The ability to rationally design and construct a platform technology to develop new platinum(IV) [Pt(IV)] prodrugs with functionalities for installation of targeting moieties, delivery systems, fluorescent reporters from a single precursor with the ability to release biologically active cisplatin by using well-defined chemistry is critical for discovering new platinum-based therapeutics. With limited numbers of possibilities considering the sensitivity of Pt(IV) centers, we used a strain-promoted azide-alkyne cycloaddition approach to provide a platform, in which new functionalities can easily be installed on cisplatin prodrugs from a single Pt(IV) precursor. The ability of this platform to be incorporated in nanodelivery vehicle and conjugation to fluorescent reporters were also investigated.Entities:
Keywords: cancer; cisplatin; click chemistry; nanoparticles; prodrugs
Mesh:
Substances:
Year: 2014 PMID: 24756923 PMCID: PMC4345128 DOI: 10.1002/chem.201402573
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.236